COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018
12/12/2018
Montrouge, France, December 12, 2018 DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 First-of-its-kind study evaluated immune profile of [...]
DBV Technologies communique des données à l'appui de l'induction de l'immunotolérance par la peau au Inflammatory Skin Disease Summit 2018
12/12/2018
Montrouge, France, le 12 décembre (07h30 CET), 2018 DBV Technologies communique des données à l'appui de l'induction de l'immunotolérance par la peau au Inflammatory Skin Disease Summit 2018 Une étude unique en son [...]
Santhera Announces Financial Results for the First Nine Months of 2018
12/12/2018
Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) reports financial results for the nine months ended September 30, 2018, and confirms its guidance and positive outlook. Santhera is on [...]
Santhera Launches Placement of Shares through Accelerated Bookbuilding
12/12/2018
Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals Holding Ltd (SIX: SANN) announces the launch of an ordinary capital increase of up to 5,000,000 registered shares with a nominal value of CHF 1 each to [...]
Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock
12/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an underwritten public [...]
DiaMedica Closes Public Offering in the United States
11/12/2018
MINNEAPOLIS, Dec. 11, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“ DiaMedica ” or the “ Company ”) (NASDAQ:DMAC; TSXV:DMA), a clinical stage biopharmaceutical company, announced today that it has completed an [...]
Intra-Cellular Therapies Announces Favorable Results From Long-Term Open-Label Safety Switching Study With Lumateperone in Patients with Schizophrenia at the 57th Annual Meeting of the American College of Neuropsychopharmacology
11/12/2018
Favorable safety results following administration of lumateperone for up to one year treatment duration are consistent with and extend the safety and tolerability profile previously reported in short-term trials Intra- [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/12/2018
MENLO PARK, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Healthcare Special Opportunities Fund Announces December 2018 Quarterly Distribution
11/12/2018
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 11, 2018 (GLOBE NEWSWIRE) -- (TSX:MDS.UN) – LDIC Inc. (the “Manager”), the manager of Healthcare Special Opportunities [...]
Quotient Limited Announces Receipt of the ISO 13485:2016 Certification of its State of the Art MosaiQ™ Microarray Manufacturing Facility
11/12/2018
JERSEY, Channel Islands, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported receipt of the formal ISO 13485:2016 certification for its [...]
Management Cease Trade Order Update
11/12/2018
HALIFAX, Nova Scotia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
Help Your Diabetes® Added To Franchise Dictionary’s Top 100 Game Changers As “One To Watch”
11/12/2018
GRAPEVINE, Texas, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Today, Help Your Diabetes®, a company that helps Type 2 Diabetics live diabetes-free lives through natural methods, announced that they have been voted into the Top [...]
NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder
11/12/2018
FORT MYERS, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that GE Medical Systems Information Technologies, Inc [...]
Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency
11/12/2018
Single, Global Pivotal Trial to Support Registration; Primary Endpoint of Arginine Reduction Expected to Initiate in Q2 2019; Topline Data Anticipated in Q1 2021 Company to Host Conference Call Today at 5:00 p.m. ET [...]
Viveve Announces Closing of Public Offering of Shares of Common Stock
11/12/2018
ENGLEWOOD, Colo., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the closing of its previously [...]
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
11/12/2018
JERSEY, Channel Islands, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the closing of its previously announced underwritten [...]
Momenta Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares
11/12/2018
CAMBRIDGE, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to [...]
Fluidigm Announces Commencement of Public Offering of Common Stock
11/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to offer and sell, subject [...]
Amicus Therapeutics Awarded United Kingdom Prix Galien Medal for Galafold® (Migalastat)
11/12/2018
First Orphan Drug to Win Prestigious “Innovative Product” Award CRANBURY, N.J. and LONDON, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, [...]

Pages